GT200500051A - Nuevos derivados de bencil (ideno)-lactamas - Google Patents
Nuevos derivados de bencil (ideno)-lactamasInfo
- Publication number
- GT200500051A GT200500051A GT200500051A GT200500051A GT200500051A GT 200500051 A GT200500051 A GT 200500051A GT 200500051 A GT200500051 A GT 200500051A GT 200500051 A GT200500051 A GT 200500051A GT 200500051 A GT200500051 A GT 200500051A
- Authority
- GT
- Guatemala
- Prior art keywords
- lactamas
- ideno
- bencil
- new derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55380804P | 2004-03-17 | 2004-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200500051A true GT200500051A (es) | 2005-10-24 |
Family
ID=34960867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200500051A GT200500051A (es) | 2004-03-17 | 2005-03-15 | Nuevos derivados de bencil (ideno)-lactamas |
Country Status (29)
Country | Link |
---|---|
US (1) | US7479559B2 (xx) |
EP (1) | EP1727794B1 (xx) |
JP (1) | JP4880583B2 (xx) |
KR (1) | KR20060124770A (xx) |
CN (1) | CN1934081A (xx) |
AP (1) | AP2006003726A0 (xx) |
AR (1) | AR050403A1 (xx) |
AT (1) | ATE533745T1 (xx) |
AU (1) | AU2005223481A1 (xx) |
BR (1) | BRPI0508825A (xx) |
CA (1) | CA2559530C (xx) |
CR (1) | CR8618A (xx) |
DO (1) | DOP2005000035A (xx) |
EA (1) | EA200601461A1 (xx) |
EC (1) | ECSP066853A (xx) |
ES (1) | ES2374629T3 (xx) |
GT (1) | GT200500051A (xx) |
IL (1) | IL178105A0 (xx) |
MA (1) | MA28474B1 (xx) |
NL (1) | NL1028558C2 (xx) |
NO (1) | NO20063602L (xx) |
PA (1) | PA8626501A1 (xx) |
PE (1) | PE20051153A1 (xx) |
SV (1) | SV2005002051A (xx) |
TN (1) | TNSN06287A1 (xx) |
TW (1) | TW200604165A (xx) |
UY (1) | UY28811A1 (xx) |
WO (1) | WO2005090300A1 (xx) |
ZA (1) | ZA200607133B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006075226A1 (en) * | 2005-01-13 | 2006-07-20 | Pfizer Products Inc. | 11c-labeled benzyl-lactam compounds and their use as imaging agents |
US20090286804A1 (en) * | 2005-06-17 | 2009-11-19 | Pfizer Inc | Metabolites of 1-[6-(1-ethyl-1-hydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one as seratonin receptor antagonists |
WO2007026219A2 (en) * | 2005-08-31 | 2007-03-08 | Pfizer Products Inc. | Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
WO2008068614A2 (en) * | 2006-12-06 | 2008-06-12 | Pfizer Products Inc. | Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one |
FR2948660B1 (fr) * | 2009-07-30 | 2011-08-19 | Oroxcell | Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent |
EP2338873A1 (en) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | New aminotetraline derivatives |
US20130065897A1 (en) * | 2009-12-23 | 2013-03-14 | Peter Maccallum Cancer Institute | Compounds, preparation and uses thereof |
DK2884978T3 (da) * | 2012-08-16 | 2019-09-30 | Scripps Research Inst | Nye Kappa-opioidligander |
US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
RU2016131875A (ru) * | 2014-01-20 | 2018-02-26 | Ф. Хоффманн-Ля Рош Аг | Производные n-фениллактама, способные стимулировать нейрогенез, и их применение при лечении заболеваний нервной системы |
WO2016144936A1 (en) | 2015-03-09 | 2016-09-15 | Bristol-Myers Squibb Company | Lactams as inhibitors of rock |
WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58189163A (ja) * | 1982-04-02 | 1983-11-04 | Takeda Chem Ind Ltd | 縮合ピロリノン誘導体 |
IL106142A (en) | 1992-06-29 | 1997-03-18 | Merck & Co Inc | Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them |
WO1994021619A1 (en) | 1993-03-16 | 1994-09-29 | Pfizer Inc. | Naphthalene derivatives |
JP3786983B2 (ja) * | 1994-01-27 | 2006-06-21 | シエーリング アクチエンゲゼルシャフト | ピロリジノン誘導体 |
GB9410512D0 (en) | 1994-05-25 | 1994-07-13 | Smithkline Beecham Plc | Novel treatment |
KR100248643B1 (ko) | 1994-06-29 | 2000-07-01 | 디. 제이. 우드 | 아릴 및 헤테로아릴 알콕시나프탈렌 유도체 |
HUP9902160A3 (en) * | 1996-03-29 | 2001-02-28 | Pfizer | Benzyl(idene)-lactam derivatives, their use as selective (ant)agonists of 5-ht1a-and/or 5-ht1d receptors, pharmaceutical compositions containing these compounds |
UA56185C2 (uk) * | 1996-09-30 | 2003-05-15 | Пфайзер Інк. | Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування |
US6423708B1 (en) * | 1996-09-30 | 2002-07-23 | Pfizer Inc | Aralkyl and aralkylidene heterocyclic lactams and imides |
DE10002509A1 (de) | 2000-01-21 | 2001-07-26 | Gruenenthal Gmbh | Substituierte Glutarimide |
US20020049211A1 (en) * | 2000-09-06 | 2002-04-25 | Sobolov-Jaynes Susan Beth | Combination treatment for depression and anxiety |
TWI263640B (en) * | 2001-12-19 | 2006-10-11 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
-
2005
- 2005-03-07 KR KR1020067019078A patent/KR20060124770A/ko not_active Application Discontinuation
- 2005-03-07 WO PCT/IB2005/000583 patent/WO2005090300A1/en active Application Filing
- 2005-03-07 AT AT05708687T patent/ATE533745T1/de active
- 2005-03-07 EP EP05708687A patent/EP1727794B1/en active Active
- 2005-03-07 JP JP2007503427A patent/JP4880583B2/ja not_active Expired - Fee Related
- 2005-03-07 EA EA200601461A patent/EA200601461A1/ru unknown
- 2005-03-07 CN CNA2005800085634A patent/CN1934081A/zh active Pending
- 2005-03-07 CA CA2559530A patent/CA2559530C/en not_active Expired - Fee Related
- 2005-03-07 AP AP2006003726A patent/AP2006003726A0/xx unknown
- 2005-03-07 AU AU2005223481A patent/AU2005223481A1/en not_active Abandoned
- 2005-03-07 BR BRPI0508825-9A patent/BRPI0508825A/pt not_active IP Right Cessation
- 2005-03-07 ES ES05708687T patent/ES2374629T3/es active Active
- 2005-03-10 DO DO2005000035A patent/DOP2005000035A/es unknown
- 2005-03-15 TW TW094107893A patent/TW200604165A/zh unknown
- 2005-03-15 UY UY28811A patent/UY28811A1/es not_active Application Discontinuation
- 2005-03-15 PE PE2005000296A patent/PE20051153A1/es not_active Application Discontinuation
- 2005-03-15 GT GT200500051A patent/GT200500051A/es unknown
- 2005-03-16 SV SV2005002051A patent/SV2005002051A/es not_active Application Discontinuation
- 2005-03-16 AR ARP050101025A patent/AR050403A1/es unknown
- 2005-03-16 NL NL1028558A patent/NL1028558C2/nl not_active IP Right Cessation
- 2005-03-17 PA PA20058626501A patent/PA8626501A1/es unknown
- 2005-03-17 US US11/083,188 patent/US7479559B2/en not_active Expired - Fee Related
-
2006
- 2006-08-09 NO NO20063602A patent/NO20063602L/no not_active Application Discontinuation
- 2006-08-25 ZA ZA200607133A patent/ZA200607133B/en unknown
- 2006-09-13 CR CR8618A patent/CR8618A/es not_active Application Discontinuation
- 2006-09-14 IL IL178105A patent/IL178105A0/en unknown
- 2006-09-15 EC EC2006006853A patent/ECSP066853A/es unknown
- 2006-09-15 TN TNP2006000287A patent/TNSN06287A1/fr unknown
- 2006-09-15 MA MA29327A patent/MA28474B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AP2006003726A0 (en) | 2006-10-31 |
ZA200607133B (en) | 2007-12-27 |
EA200601461A1 (ru) | 2007-02-27 |
SV2005002051A (es) | 2005-12-13 |
CN1934081A (zh) | 2007-03-21 |
KR20060124770A (ko) | 2006-12-05 |
TW200604165A (en) | 2006-02-01 |
ES2374629T3 (es) | 2012-02-20 |
CR8618A (es) | 2006-11-15 |
JP4880583B2 (ja) | 2012-02-22 |
DOP2005000035A (es) | 2005-10-31 |
IL178105A0 (en) | 2006-12-31 |
PA8626501A1 (es) | 2005-11-25 |
UY28811A1 (es) | 2005-10-31 |
TNSN06287A1 (fr) | 2007-12-03 |
NL1028558A1 (nl) | 2005-09-20 |
AR050403A1 (es) | 2006-10-25 |
EP1727794A1 (en) | 2006-12-06 |
BRPI0508825A (pt) | 2007-08-14 |
US7479559B2 (en) | 2009-01-20 |
NL1028558C2 (nl) | 2006-06-27 |
CA2559530A1 (en) | 2005-09-29 |
WO2005090300A1 (en) | 2005-09-29 |
ATE533745T1 (de) | 2011-12-15 |
NO20063602L (no) | 2006-09-08 |
CA2559530C (en) | 2012-04-24 |
EP1727794B1 (en) | 2011-11-16 |
MA28474B1 (fr) | 2007-03-01 |
PE20051153A1 (es) | 2006-01-28 |
ECSP066853A (es) | 2006-11-24 |
AU2005223481A1 (en) | 2005-09-29 |
US20050245521A1 (en) | 2005-11-03 |
JP2007529495A (ja) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200500051A (es) | Nuevos derivados de bencil (ideno)-lactamas | |
GT200800258A (es) | Compuestos de pirrolo-pirimidina y sus usos | |
GT200600197A (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
GT200400013A (es) | Compuestos de pirazolotriazina y usos de los mismos | |
GT200500292A (es) | Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
GT200600167A (es) | Derivados de dihidrobenzofurano y usos de los mismos | |
GT200500103A (es) | 4-fenilamino-quinazolin-6-il-amidas | |
UY29267A1 (es) | Derivados de piperidina y su uso como agentes antiinflamatorios | |
EA201001356A1 (ru) | Новые замещенные имидазохинолины | |
ECSP067121A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
ECSP088623A (es) | Derivados de azepinoindol como agentes farmacéuticos | |
ECSP055676A (es) | Piperazinas heterocíclicas sustituidas para el tratamiento de la esquizofrenia | |
CR8254A (es) | [1,8] naftidrin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
MA29135B1 (fr) | Potentialisateurs de recepteurs du glutamate | |
NI200900100A (es) | Antagonistas de receptor de orexina de diazepan sustituido | |
GT200600107A (es) | Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos | |
GT200500238A (es) | Fenilaminotiazoles sustituidos y su uso | |
GT200300033A (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
NO20071476L (no) | Antidiuretiske midler. | |
CR10060A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
CR20110381A (es) | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2 | |
CY1108880T1 (el) | Παραγωγα καρβοξαμιδιου ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
GT200300263A (es) | Derivados de indazol como antagonistas del crf | |
GT200600017A (es) | 4-feniltetrahidroisoquinolinas sustituidas, proceso para su preparacion, su uso como medicamento y medicamento que las comprende |